FDA warns Indian API supplier or data integrity lapses, Chinese contract lab for inadequate testing
Regulatory NewsJoanne S. Eglovitch
APIsAudit/inspectionCDERChemistry, Manufacturing and Controls (CMC)ContaminantsGMPOTCPharmaceuticalsQuality Assurance and ControlUnited StatesWarning letters